We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.7B
AUM Growth
+$2.29B
Cap. Flow
+$341M
Cap. Flow %
1.23%
Top 10 Hldgs %
18.59%
Holding
1,249
New
118
Increased
427
Reduced
427
Closed
119

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$113M
2
AAPL icon
Apple
AAPL
+$69M
3
PFE icon
Pfizer
PFE
+$57M
4
VZ icon
Verizon
VZ
+$50.4M
5
MSFT icon
Microsoft
MSFT
+$48.6M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$100M
2
LIN icon
Linde
LIN
+$85.1M
3
ABMD
Abiomed Inc
ABMD
+$55.4M
4
RACE icon
Ferrari
RACE
+$51.7M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 27.12%
2 Healthcare 20.97%
3 Financials 10.86%
4 Consumer Discretionary 10.19%
5 Industrials 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIG icon
526
American International
AIG
$39.8B
$5.89M 0.02%
93,216
-103,233
-53% -$6.01M
KMI icon
527
Kinder Morgan
KMI
$68.4B
$5.89M 0.02%
325,562
-15,453
-5% -$278K
FTV icon
528
Fortive
FTV
$16.7B
$5.86M 0.02%
120,955
+52,729
+77% +$2.55M
AVY icon
529
Avery Dennison
AVY
$13.1B
$5.79M 0.02%
31,979
+6,746
+27% +$1.2M
SFM icon
530
Sprouts Farmers Market
SFM
$6.63B
$5.78M 0.02%
178,700
+150,500
+534% +$4.68M
DBX icon
531
Dropbox
DBX
$8.21B
$5.78M 0.02%
258,279
+210,244
+438% +$4.63M
CHE icon
532
Chemed
CHE
$6.66B
$5.77M 0.02%
+11,300
New +$5.5M
WTS icon
533
Watts Water Technologies
WTS
$11.6B
$5.75M 0.02%
39,345
PPG icon
534
PPG Industries
PPG
$23.3B
$5.72M 0.02%
45,528
+35,666
+362% +$4.37M
TVTX icon
535
Travere Therapeutics
TVTX
$5.98B
$5.7M 0.02%
271,212
-5,285
-2% -$112K
AON icon
536
Aon
AON
$63.8B
$5.67M 0.02%
18,885
-63,206
-77% -$18.5M
EQH icon
537
Equitable Holdings
EQH
$14.7B
$5.66M 0.02%
197,269
+64,777
+49% +$1.92M
DINO icon
538
HF Sinclair
DINO
$20.3B
$5.65M 0.02%
108,900
+19,500
+22% +$1.12M
RXDX
539
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$5.64M 0.02%
+51,313
New +$3.33M
SEDG icon
540
SolarEdge
SEDG
$2.13B
$5.64M 0.02%
19,896
+11,002
+124% +$2.92M
NUE icon
541
Nucor
NUE
$59.1B
$5.62M 0.02%
42,606
-172,524
-80% -$23.4M
LOPE icon
542
Grand Canyon Education
LOPE
$4.01B
$5.6M 0.02%
52,953
+2,276
+4% +$227K
OSW icon
543
OneSpaWorld
OSW
$2.2B
$5.58M 0.02%
597,600
-800,890
-57% -$7.58M
BFAM icon
544
Bright Horizons
BFAM
$3.34B
$5.53M 0.02%
87,588
-2,024
-2% -$132K
PRGO icon
545
Perrigo
PRGO
$1.88B
$5.52M 0.02%
162,025
+14,300
+10% +$504K
ETSY icon
546
Etsy
ETSY
$6.74B
$5.52M 0.02%
46,055
-64,387
-58% -$7.37M
MKC icon
547
McCormick & Company Non-Voting
MKC
$13.5B
$5.46M 0.02%
65,814
-109,154
-62% -$8.8M
GNTX icon
548
Gentex
GNTX
$4.7B
$5.39M 0.02%
197,531
-9,062
-4% -$242K
USFD icon
549
US Foods
USFD
$20B
$5.38M 0.02%
158,200
-55,800
-26% -$1.78M
DEA
550
Easterly Government Properties
DEA
$1.1B
$5.36M 0.02%
150,364
+33,949
+29% +$1.32M

Similar funds

Axa's Q4 2022 Portfolio in Review

As of Q4 2022, Axa held 1,249 positions worth $27.7B, up 9% from $25.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2022 filing shows 118 new, 427 increased, 427 reduced and 119 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M. The largest sale was Oracle, an estimated $100M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2022 buy was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M.
  • Axa added most to Tesla in Q4 2022, an estimated $113M increase.
  • Axa's biggest Q4 2022 reduction was Oracle, cutting an estimated $100M.
  • Axa fully exited Abiomed Inc in Q4 2022, selling an estimated $55.4M.
  • Axa's ten largest holdings make up 19% of its $27.7B portfolio in Q4 2022.
  • Axa opened 118 new positions and closed 119 in Q4 2022.
  • Axa's portfolio value rose 9% quarter-over-quarter to $27.7B.

Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.